Gees at one stage I thought we could reach $150-200M market cap.
if we have a $120k price per procedure. And using a P/E of 30 for a growth stock. Then that is earnings of around $5-6million. Margin 45%. Then revenue would need to be $18m per year. Or 150 patients. Form say 20 sites. That would be say 8 per site per annum. Doesn’t sound like such an ambitious target.
Why then haven’t they achieved it to date. Their product is effective in resections and extending life to the fortunate ones.
Gees at one stage I thought we could reach $150-200M market cap....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.015(1.48%) |
Mkt cap ! $14.65M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | 95.0¢ | $109.7K | 112.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23906 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 2292 | 2 |
View Market Depth
| Last trade - 15.57pm 19/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |